Skip Navigation
 
 
 
 
Wilmer Eye Institute
 
Print This Page
Share this page: More
 

Eye Tumors

Eye Tumors

Tumors in the eye usually are secondary tumors caused by cancers that have spread from other parts of the body, especially the breast, lung, bowel or prostate. Two types of primary tumors arise within the eye itself and are known as retinoblastoma in children and melanoma in adults.

Retinoblastoma is a cancer of the retina, the eye's light-sensitive tissue. This most common childhood eye cancer usually strikes children under age five, affecting 500 to 600 in the United States each year. In nearly a third of the cases, retinoblastoma occurs in both eyes. While symptoms are not evident early in the disease, increasing pain and vision loss eventually signal the problem.

Malignant melanoma occurs most frequently in adults 60 to 65 years of age, arising from uncontrolled growth of cells called melanocytes. From 1,500 to 2,000 new cases are diagnosed annually in the United States.

Diagnosis:

In addition to damaging vision, eye tumors can spread to the optic nerve, the brain and the rest of the body. Therefore, early diagnosis and treatment are extremely important. Melanoma tends to spread via blood vessels to distant organs. Wilmer ophthalmologists and other highly skilled physicians, like the pathologist, play a crucial role in making the precise diagnosis and in determining the progression of the tumor. Tumor cells are studied in the Wilmer Eye Pathology Laboratory, a world leader in diagnosing eye tumors. Physicians from the Johns Hopkins Melanoma Clinic are involved when their expertise is necessary.

For children, much of the diagnostic work takes place in what appears to be a playroom and involves techniques designed to be child-friendly.

Treatment:

There are various ways to treat eye tumors, depending on the diagnosis, size and aggressiveness of the tumor, and other factors. Certain small tumors may respond to laser treatment or freezing (cryosurgery). In some instances, it is possible to remove a tumor surgically and still preserve vision. A technique advanced by Wilmer researchers fine-tunes radiation therapy for eye tumors, focusing it more precisely on the eye. This minimizes the amount of radiation reaching healthy tissue. If the eye cancer is advanced and must be treated aggressively or removed, plastic surgeons at Wilmer perform reconstructive eye surgery. Today's artificial eyes or implants move almost normally and are virtually indistinguishable from natural eyes, although, of course, they do not see.

> Treated by the Division of Ocular Oncology

The Future:

Researchers at Wilmer are studying hereditary patterns in childhood cancers of the eye. For families with a history of eye cancer, preventive measures and early detection programs can help alleviate some anxieties and minimize damage. For adult eye tumors, Wilmer researchers are conducting extensive clinical trials to see which treatments provide the best outcome. Simultaneous quality-of-life studies will show patients' preferences and which approaches yield the best function.

Dr. Sheila West on the Link Between Smoking and Eye Disease in Women - 7/23/2014

Dr. Pradeep Ramulu and Colleagues Study Relationship Between Vision Loss and Work Status - 7/18/2014

Wilmer Resident Receives Lindstrom Research Grant - 7/11/2014

Four Wilmer Researchers Receive BrightFocus Foundation Awards - 7/10/2014

Dr. Michael Repka Part of Team Researching Telemedicine and ROP - 6/27/2014

Dr. M. Valeria Canto-Soler and Colleagues Featured on WBAL-TV - 6/24/2014

Dr. M. Valeria Canto-Soler and Colleagues Use Human Stem Cells to Create Light-Sensitive Retina in a Dish - 6/10/2014

Wilmer's Division of Ocular Immunology Announces "Living With Uveitis" Support Group - 6/10/2014

Dr. Neil Bressler to Speak on Diabetic Retinopathy at National Eye Health Summit and Webcast - 6/10/2014

Dr. Donald Zack Receives a Research to Prevent Blindness Nelson Trust Award for Retinitis Pigmentosa - 6/9/2014

Dr. Michael Boland Leads Study on Effectiveness of Automated Telecommunication-Based Reminders on Adherence to Glaucoma Medication Dosing - 6/4/2014

Dr. Christina Prescott Discusses Summer Eye Protection on Fox 45 News - 6/1/2014

Dr. Jonathan Song Discusses Treatment Options for Pediatric Cataracts - 5/23/2014

Johns Hopkins' Jordan Green Discusses His Work at Wilmer's Translational Tissue Engineering Center - 5/21/2014

Longtime Wilmer Employee Lillie Alston Honored by Hopkins - 5/19/2014

Dr. Richard Semba: Diets Rich in Antioxidant Resveratrol Fail to Reduce Deaths, Heart Disease or Cancer - 5/12/2014

Dr. Neil Miller Explains Eye Twitching in The Wall Street Journal - 5/12/2014

Dr. Hendrik Scholl Receives ARVO Award - 5/7/2014

 

Traveling for care?

blue suitcase

Whether crossing the country or the globe, we make it easy to access world-class care at Johns Hopkins.

U.S. 1-410-464-6713 (toll free)
International +1-410-614-6424

 

 
 
 
 
 

© The Johns Hopkins University, The Johns Hopkins Hospital, and Johns Hopkins Health System. All rights reserved.

Privacy Policy and Disclaimer